The early toxicity testing market accounted for $1,301 million by 2028, registering a CAGR of 7.3% from 2022 to 2025. Early toxicity tests are performed at the preclinical stage of the new drug development process, and toxicity is essential because it acts as a major cause of failure of potential drug candidates in the later stages of new drug […]
